Supplementary Tables from LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion

Supplementary Table S1-S4. Table S1. Correlation between expression of LOXL2 or its spliced isoform L2Δ13 and clinicopathological characteristics in ESCC patients of cohort 1 (n = 252). Table S2. Patient demographics and clinical characteristics for tissue microarray cohort 2 in ESCC (n = 135). Table S3. Multivariate Cox regression for overall survival and disease-free survival of ESCC patients (n = 252). Table S4. Interacting proteins associated with LOXL2 and L2Δ13 in KYSE150 ESCC cells identified by high-performance liquid chromatography followed by tandem mass spectrometry (LC-MS/MS) analysis.